Link between defects in DNA replication and loss of heterochromatin.
The histone variants macroH2A are tumor suppressors that are down regulated or lost in several solid cancers and leukemia
This work was led by Dr. Maria Joao Baptista, Dr. Isabel Granada and Dr. Francesc Solé.
The Germans Trias i Pujol Institute on Health Sciences Foundation (IGTP), the Catalan Institute for Oncology (ICO) and the Josep Carreras Leukaemia Research Institute (IJC) have signed a collaboration agreement to promote scientific research into leukaemia and other malignant blood diseases
In the past March 10th, Professor Georg Lenz, from the Translational Oncology Department of Medicine A, Universitätsklinikum Münster, was at the campus IJC-Badalona to gave a talk entitle “Novel insights into the molecular pathogenesis of aggressive lymphoma subtypes and their clinical implications”.
Dr. Emili Cid, a postdoctoral fellow at the Immunohematology and Glycobiology Group of the Josep Carreras Leukaemia Research Institute has published a paper in the journal Nature Scientific Reports.
Miyako Yamamoto and her colleagues at the Immunohematology and Glycobiology Group at the Josep Carreras Leukaemia Research Institute have published a paper entitled “Crosstalk between ABO and Forssman (FORS) blood group systems: FORS1 antigen synthesis by ABO gene-encoded glycosyltransferases” in the journal Scientific Reports.
A young researcher in the Risueño group publishes a paper in Leukemia
Marcus Buschbeck and Sandra Hake have published an article on the state of the art in histone biology in Nature Reviews Molecular Cell Biology.